deltatrials
Terminated PHASE3 INTERVENTIONAL 1-arm NCT02374567

Pharmacovigilance in Gerontopsychiatric Patients (GAP)

Sponsor: Hannover Medical School

Conditions Anxiety Disorders Dementia Depression Psychosomatic Disorders Schizophrenia
Interventions Acamprosate Agomelatine Alprazolam Amisulpride Amitriptyline Amitriptyline oxide Aripiprazole Benperidol Biperiden Bromazepam Bromperidol Brotizolam Bupropion Buspirone Carbamazepine Chloral Hydrate Chlorprothixene Citalopram Clobazam Clomethiazole Clomipramine Clonazepam Clozapine Diazepam Diphenhydramine Donepezil Doxepin Duloxetine Escitalopram Fluoxetine Flupentixol Fluphenazine Flurazepam Fluspirilene Fluvoxamine Gabapentin Galantamine Haloperidol Hydroxyzine Imipramine Lacosamide Lamotrigine Levetiracetam Levomepromazine Lithium Lorazepam Lormetazepam Maprotiline Melatonin Melperone Memantine Mianserin Midazolam Mirtazapine Moclobemide Nicergoline Nitrazepam Nortriptyline Olanzapine Opipramol Oxazepam Oxcarbazepine Paliperidone Paroxetine Perazine Perphenazine Phenobarbital Phenytoin Pimozide Pipamperone Piracetam Pregabalin Promethazine Prothipendyl Pyritinol Quetiapine Reboxetine Risperidone Rivastigmine Sertindole Sertraline Sulpiride Temazepam Thioridazine Tiapride Topiramate Tranylcypromine Trazodone Triazolam Trimipramine Valproic Acid Venlafaxine Zaleplon Ziprasidone Zolpidem Zopiclone Zuclopenthixol
Updated 7 times since 2017 Last updated: Feb 27, 2018 Started: Jan 31, 2015 Primary completion: Jun 28, 2017 Completion: Jun 28, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Hannover Medical School

See all terminations from Hannover Medical School

Other Anxiety Disorders trials with similar outcome

Browse all Anxiety Disorders trials

A PHASE3 clinical study on Anxiety Disorders and Dementia, this trial is terminated or withdrawn. The trial is conducted by Hannover Medical School and has accumulated 7 data snapshots since 2015. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

~Jan 2017 – ~Nov 2017 · 10 months · monthly snapshotRecruiting~Nov 2017 – ~Jun 2018 · 7 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

▶ Show 2 earlier versions

  1. Nov 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    Status: Recruiting → Terminated

  2. Jan 2017 — Nov 2017 [monthly]

    Recruiting PHASE3

    First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hannover Medical School
Data source: Hannover Medical School

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations